Apple (NASDAQ:AAPL) supplier stocks in China fell on Monday after U.S. President Donald Trump threatened a new wave of tariffs targeting imported iPhones. Shares of Luxshare, a key iPhone assembler and AirPods maker, dropped 2.2%, while mobile screen supplier Lens Technology slid 1.8%. Goertek, another AirPods producer, declined 1.1%.
Trump warned Friday that he may impose a 25% tariff on iPhones sold in the U.S. but manufactured overseas, as part of his administration’s push to bring jobs back to America. The comment sparked fears of a renewed escalation in U.S.-China trade tensions, just as markets had begun to stabilize following earlier tariff pauses.
In April, the White House had eased its sweeping tariff measures after a sharp sell-off in U.S. assets, including government bonds and the dollar. Although the administration scaled back its aggressive 145% tariff on Chinese goods to 30%, a baseline 10% tax remains in place on most imports.
To counter future tariff risks, Apple is accelerating its shift in production away from China. The company plans to manufacture the majority of iPhones sold in the U.S. in India by the end of 2026. However, relocating production to the U.S. appears unlikely in the short term due to current technological constraints.
Commerce Secretary Howard Lutnick previously suggested iPhone manufacturing could be reshored and automated to create jobs for U.S. skilled workers. Yet he later clarified that Apple CEO Tim Cook noted the required automation technology does not yet exist.
Apple’s global supply chain remains under pressure as geopolitical risks mount, with potential tariffs posing significant challenges to operations and supplier stock performance.


Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges
Washington Post Publisher Will Lewis Steps Down After Layoffs
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
New York Legalizes Medical Aid in Dying for Terminally Ill Patients
Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 



